SET7/9 antibody | knockout validation | Cell Signaling Technology 2813
DOI
//dx.doi.org/10.13070/ko.en.6.1894
Date
2016-11-30

This is a knockout-validated antibody summary, based on the publication "TITLE", as cited below [1]. Labome curates formal publications to compile a list of antibodies with unambiguous specificity within Validated Antibody Database (VAD).

SET7/9 antibody | knockout validation | Cell Signaling Technology 2813 figure 1
Figure 1. Western blot of SET7/9 in WT and Set7/9−/− MEFs. Beta-actin was used as loading control. From [1].
Antibody information

Company: Cell Signaling Technology

Antibody: SET7/9

Catalog number: 2813

Summary: Rabbit polyclonal against a synthetic peptide corresponding to the human SET7/SET9 protein. Reacts with human, mouse, rat, and monkey. Suitable for western blot and immunofluorescence/immunocytochemistry.

Validation Method

Western blot

Sample

WT and Set7/9−/− MEFs.

Primary incubation

1:1,000 dilution in 3% BSA diluted in PBS-T.

Secondary incubation

Horseradish peroxidase-conjugated secondary antibody (Jackson).

Detection

LumiFlash Ultima Chemiluminescent substrate (Visual Protein) and LAS-4000 mini (Fuji).

Disclaimer

If the antibody described in this summary is a polyclonal antibody, since polyclonal antibodies are of limited quantity, please inquire the supplier whether any current polyclonal antibody with the same catalog number is exactly the same as the one described in this summary. Sometimes, different bleeds or different animals are used, usually with a different lot number. In such cases, the result in this summary may not apply to the new antibody with the same catalog number.

References
  1. Kim Y, Nam H, Lee J, Park D, Kim C, Yu Y, et al. Methylation-dependent regulation of HIF-1α stability restricts retinal and tumour angiogenesis. Nat Commun. 2016;7:10347 pubmed publisher